Antigenic modulation and receptor loss in experimental autoimmune myasthenia gravis
โ Scribed by Dr. Jon Lindstrom; Brett Einarson
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- English
- Weight
- 611 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0148-639X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Immunization of groups of rats with 0.1โ100 ฮผg of acetylcholine receptor (AChR) purified from the electric organ of Torpedo californica resulted in doseโdependent (1) loss of acetylcholine receptor from the rats' muscles, (2) binding of antibodies to many of the receptors remaining in muscle, and (3) production of antibodies in serum capable of crossโreacting with receptor solubilized from rat muscle. Addition of antibodies from rats immunized with electric organ acetylcholine receptors to muscle cells in culture caused loss of receptor by accelerating the rate of receptor degradation. Monovalent antibody fragments did not accelerate degradation unless antiantibody was added to crossโlink the monovalent antibody fragments bound to receptors. This indicates that crossโlinking of receptors by antibody molecules triggers accelerated receptor degradation, leading to receptor loss. The rate of increase in receptor destruction due to antigenic modulation observed in vitro appears sufficient to account for the extent of receptor loss observed in vivo. Endocytosis of antibody crossโlinked receptors may be a rateโlimiting step common to antigenic modulation in vitro and in vivo.
๐ SIMILAR VOLUMES
## Abstract A mouse model of MG, termed experimental autoimmune myasthenia gravis (EAMG), can be obtained after immunization with __Torpedo__ acetylcholine receptor (AChR). Although many studies have detailed the consequence of AChR antibodies binding at the neuromuscular junction and the difficult
Myasthenia gravis (MG) is a neuromuscular disorder of man caused by a humoral response to the acetylcholine receptor (AChR). Most of the antibodies in MG and in experimental autoimmune myasthenia gravis (EAMG) are directed to the extracellular portion of the AChR alpha subunit, and within it, primar
## Abstract Use of the mouse model of myasthenia gravis (murine EAMG), ideally suited for immunological study, has been hampered by the relatively mild character of the disease and by the extended time and effort required for inducing severe disease. Electromyographic measurement of the compound ac